Nuclear Medicine Equipment Market Growth and Demand Forecast 2024-2032

Global Nuclear Medicine Equipment Market Statistics: USD 5.2 Billion Value by 2032

Summary:

• The global nuclear medicine equipment market size reached USD 3.1 Billion in 2023.
• The market is expected to reach USD 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.
• North America leads the market, accounting for the largest nuclear medicine equipment market share.
• Single-photon emission computed tomography accounts for the majority of the market share in the product segment. 
• Oncology holds the largest share in the nuclear medicine equipment industry.
• Hospitals represent the leading end user segment.
• The growing government support and funding is a primary driver of the nuclear medicine equipment market.
• Technological advancements and the rising adoption of personalized medicine are reshaping the nuclear medicine equipment market.

Industry Trends and Drivers:

• Technological advancements in imaging: 

Innovations in image resolution, sensitivity, and speed are allowing healthcare professionals to achieve more accurate and detailed diagnostic insights. Hybrid systems, such as positron emission tomography-computed tomography (PET/CT) and single-photon emission computed tomography/computed tomography (SPECT/CT), combine functional and anatomical imaging, providing comprehensive diagnostic data in a single scan, which improves disease detection and treatment planning. These integrated technologies help clinicians monitor disease progression with greater accuracy, reducing the need for multiple tests and invasive procedures. Additionally, artificial intelligence (AI)-driven solutions are beginning to be incorporated into nuclear imaging systems, automating image analysis and improving diagnostic precision. These advancements not only enhance clinical outcomes but also improve operational efficiency as the systems become more user-friendly and reduce the need for manual interpretation.

• Growing government support and funding: 

In many countries, governing bodies are allocating notable resources to improve healthcare infrastructure and expand access to advanced medical technologies. This includes providing financial incentives, grants, and subsidies to healthcare institutions for the acquisition of nuclear medicine equipment. This support is particularly important for public hospitals and clinics that may need more financial resources to invest in cutting-edge diagnostic tools. Additionally, regulatory agencies in many regions are actively promoting the development and adoption of nuclear medicine through streamlined approval processes and safety guidelines. In developing countries, governments are also recognizing the importance of nuclear medicine for improving healthcare outcomes and are increasingly investing in nuclear imaging facilities to address rising healthcare demands.

• Rising adoption of personalized medicine:

Personalized medicine tailors medical treatment to individual characteristics, such as genetic makeup and specific disease conditions, rather than following a one-size-fits-all approach. Nuclear medicine imaging provides essential data that allows physicians to customize treatment plans for each patient. In oncology, positron emission tomography (PET) scans can determine the exact location and metabolic activity of tumors, helping oncologists design targeted therapies that maximize effectiveness while minimizing side effects. This approach is also used in cardiology and neurology, where nuclear imaging helps to assess individual responses to treatments, allowing for fine-tuned adjustments. The growing adoption of personalized medicine in modern healthcare is driving the demand for nuclear imaging equipment that supports this level of detailed analysis.

Request for a sample copy of this report: https://www.imarcgroup.com/nuclear-medicine-equipment-market/requestsample

Nuclear Medicine Equipment Market Report Segmentation:

Breakup By Product:

• Single-Photon Emission Computed Tomography
  • Standalone
  • Hybrid
• Positron Emission Tomography
  • Standalone
  • Hybrid
• Planar Scintigraphy

Single-photon emission computed tomography exhibits a clear dominance in the market attributed  to its widespread use in diagnostic imaging for a variety of conditions and its cost-effectiveness compared to other imaging modalities.

Breakup By Application:

• Neurology
• Oncology
• Cardiology
• Others

Oncology holds the biggest market share owing to the critical role of nuclear medicine equipment in cancer diagnosis, staging, and treatment monitoring.

Breakup By End User:

• Hospitals
• Imaging Centers
• Academic and Research Institutes
• Others

Hospitals account for the majority of the market share, as they are the primary facilities utilizing nuclear medicine equipment for diagnostic and therapeutic purposes.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market due to advanced healthcare infrastructure, rising adoption of nuclear medicine technologies, and favorable reimbursement policies.

Top Nuclear Medicine Equipment Market Leaders:

The nuclear medicine equipment market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Biodex Medical Systems Inc. (Mirion Technologies Inc.)
• Cardinal Health Inc.
• CMR Naviscan Corporation
• DDD-Diagnostic A/S
• Digirad Corporation
• General Electric Company
• Koninklijke Philips N.V.
• Mediso Ltd.
• Neusoft Corporation
• Siemens AG
• SurgicEye GmbH
• Toshiba Corporation

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–631–791–1145